Search
+
    SEARCHED FOR:

    DR RAJIV BAHL

    ET Industry Changemakers Awards North 2026: Celebrating Visionaries Who Are Shaping Tomorrow
    Before Ayushman Bharat, families sold their homes to afford treatment: J P Nadda

    Union Health Minister J P Nadda said on Friday that the Ayushman Bharat Pradhan Mantri Jan Arogya Yojana has transformed India's healthcare. He said the scheme covered over 60 crore beneficiaries, becoming the world's largest health assurance programme. The scheme has over 5.6 lakh health facilities and around 11 lakh healthcare professionals are registered on the ABDM ecosystem. The Union Minister also highlighted other major healthcare initiatives undertaken the incumbent government.

    No new strain of H1N1 identified, current surge part of seasonal influenza pattern: ICMR DG

    The ICMR director general stated H1N1 infections are seasonal and not a new strain. Most cases are mild and self-limiting, requiring no widespread panic. Current circulating viruses align with seasonal patterns observed in recent years. Individuals at higher risk should exercise caution and seek medical advice. Routine hygiene and avoiding unnecessary medication are advised for public protection.

    Delhi's LNJP Hospital readies 70-bed backup ward to handle potential surge in H1N1 cases

    In response to the growing concern about H1N1, Lok Nayak Jai Prakash Narayan Hospital has launched a dedicated isolation ward for affected individuals. As the H1N1 strain of Influenza A takes precedence among respiratory pathogens in India, the hospital stands ready to enhance its medical infrastructure if the situation demands. The country’s real-time disease surveillance system efficiently tracks viral outbreaks, ensuring immediate alerts on increasing respiratory infection rates.

    ICMR licenses cancer, vaccine technologies to Emcure, Biological E

    The Indian Council of Medical Research has licensed three new biomedical technologies. These innovations aim to advance cancer treatment and infectious disease protection. One drug candidate targets precancerous cervical cells, offering a safer treatment option. Two vaccine candidates will combat major bacterial gut infections. This initiative promotes government research into practical healthcare products.

    India should chart own path in treatment of rare diseases: ICMR chief

    India is taking a groundbreaking step forward in the realm of rare disease care with a distinctive approach that champions local ingenuity and smart resource allocation. By shifting away from conventional Western practices, India is crafting a solution tailored to its own needs.

    The Economic Times
    BACK TO TOP